Mechelen, Belgium; 16 May 2024, 22:01 CET; regulated information – Galapagos NV (Euronext & NASDAQ: GLPG) announced today that its Board of Directors created 1,614,000 subscription rights under new subscription right plans for the benefit of certain members of the personnel of the company and its subsidiaries. On 16 May 2024, the Board of Directors of Galapagos approved “Subscription Right Plan 2024 BE”, intended for members of personnel of the company, “Subscription Right Plan 2024 RMV,” intend
BCA's national network of blood centers will provide decentralized manufacturing services for Galapagos' CAR-T product candidates, close to cancer treatment centersCollaboration enables rapid deployment of Galapagos' decentralized CAR-T platform across the U.S., improving patient access to potentially life-saving CAR-T treatmentsImportant milestone for Galapagos' U.S. expansion strategy, supporting upcoming pivotal trials and potential future commercial manufacturing of CAR-T therapiesComplement
Galapagos NV (NASDAQ:GLPG) Q1 2024 Earnings Call Transcript May 4, 2024 Galapagos NV isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Sofie Van Gijsel: Welcome all to the audio webcast of Galapagos’ Q1 2024 Results. I’m Sofie Van Gijsel, Investor Relations […]